Chesley Taft & Associates LLC Novartis Ag Transaction History

Chesley Taft & Associates LLC

  • $2.13 Billion
  • Q4 2024

A detailed history of Chesley Taft & Associates LLC transactions in Novartis Ag stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 32,347 shares of NVS stock, worth $3.41 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
32,347
Previous 33,502 3.45%
Holding current value
$3.41 Million
Previous $3.85 Million 18.32%
% of portfolio
0.15%
Previous 0.19%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
SELL
$96.78 - $117.18 $111,780 - $135,342
-1,155 Reduced 3.45%
32,347 $3.15 Million
Q3 2024

Oct 07, 2024
BUY
$106.13 - $120.89 $116,743 - $132,979
1,100 Added 3.39%
33,502 $3.85 Million
Q2 2024

Jul 19, 2024
SELL
$92.57 - $107.37 $28,696 - $33,284
-310 Reduced 0.95%
32,402 $3.45 Million
Q1 2024

Apr 15, 2024
SELL
$95.27 - $108.47 $33,344 - $37,964
-350 Reduced 1.06%
32,712 $3.16 Million
Q4 2023

Jan 11, 2024
BUY
$92.27 - $101.54 $9,227 - $10,154
100 Added 0.3%
33,062 $3.34 Million
Q3 2023

Oct 10, 2023
BUY
$94.73 - $105.13 $11,841 - $13,141
125 Added 0.38%
32,962 $3.36 Million
Q2 2023

Jul 17, 2023
SELL
$92.52 - $104.91 $46,260 - $52,455
-500 Reduced 1.5%
32,837 $3.31 Million
Q1 2023

Apr 11, 2023
BUY
$80.03 - $92.81 $12,004 - $13,921
150 Added 0.45%
33,337 $3.07 Million
Q4 2022

Jan 19, 2023
SELL
$75.55 - $92.52 $87,638 - $107,323
-1,160 Reduced 3.38%
33,187 $0
Q3 2022

Oct 13, 2022
SELL
$74.61 - $87.26 $26,113 - $30,541
-350 Reduced 1.01%
34,347 $2.61 Million
Q2 2022

Jul 07, 2022
SELL
$80.52 - $93.75 $64,416 - $75,000
-800 Reduced 2.25%
34,697 $2.93 Million
Q1 2022

Apr 14, 2022
SELL
$80.11 - $90.62 $157,015 - $177,615
-1,960 Reduced 5.23%
35,497 $3.29 Million
Q4 2021

Jan 05, 2022
SELL
$79.7 - $88.13 $77,707 - $85,926
-975 Reduced 2.54%
37,457 $3.28 Million
Q3 2021

Oct 05, 2021
SELL
$81.78 - $95.14 $19,627 - $22,833
-240 Reduced 0.62%
38,432 $3.14 Million
Q2 2021

Jul 07, 2021
BUY
$85.24 - $94.15 $39,210 - $43,309
460 Added 1.2%
38,672 $3.53 Million
Q1 2021

Apr 06, 2021
SELL
$83.5 - $98.47 $1.45 Million - $1.7 Million
-17,308 Reduced 31.17%
38,212 $3.34 Million
Q4 2020

Jan 11, 2021
BUY
$78.07 - $94.43 $88,609 - $107,178
1,135 Added 2.09%
55,520 $5.24 Million
Q3 2020

Oct 08, 2020
BUY
$82.14 - $91.0 $80,415 - $89,089
979 Added 1.83%
54,385 $4.73 Million
Q2 2020

Jul 08, 2020
SELL
$80.93 - $91.1 $35,851 - $40,357
-443 Reduced 0.82%
53,406 $4.66 Million
Q1 2020

Apr 15, 2020
SELL
$70.67 - $99.01 $46,288 - $64,851
-655 Reduced 1.2%
53,849 $4.44 Million
Q4 2019

Jan 10, 2020
SELL
$84.35 - $95.37 $85,193 - $96,323
-1,010 Reduced 1.82%
54,504 $5.16 Million
Q3 2019

Oct 07, 2019
SELL
$85.54 - $94.26 $2,908 - $3,204
-34 Reduced 0.06%
55,514 $4.82 Million
Q2 2019

Jul 10, 2019
BUY
$75.4 - $92.8 $73,439 - $90,387
974 Added 1.78%
55,548 $5.07 Million
Q1 2019

Apr 05, 2019
SELL
$75.32 - $86.15 $26,211 - $29,980
-348 Reduced 0.63%
54,574 $5.25 Million
Q4 2018

Jan 07, 2019
SELL
$73.66 - $82.02 $88,612 - $98,670
-1,203 Reduced 2.14%
54,922 $4.71 Million
Q3 2018

Oct 12, 2018
BUY
$66.94 - $77.43 $45,853 - $53,039
685 Added 1.24%
56,125 $4.84 Million
Q2 2018

Jul 12, 2018
SELL
$64.91 - $73.36 $423,602 - $478,747
-6,526 Reduced 10.53%
55,440 $4.19 Million
Q1 2018

Apr 11, 2018
SELL
$70.39 - $84.15 $30,690 - $36,689
-436 Reduced 0.7%
61,966 $5.01 Million
Q4 2017

Jan 10, 2018
SELL
$72.33 - $77.64 $6,220 - $6,677
-86 Reduced 0.14%
62,402 $5.24 Million
Q3 2017

Oct 13, 2017
BUY
$74.14 - $77.27 $4.63 Million - $4.83 Million
62,488
62,488 $5.37 Million

Others Institutions Holding NVS

# of Institutions
1,468
Shares Held
134M
Call Options Held
1.4M
Put Options Held
1.61M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Chesley Taft & Associates LLC Portfolio

Follow Chesley Taft & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email